Dysphagia in inflammatory myopathy: Self-report, incidence, and prevalence

Dysphagia

Volumn 27, Issue 1, 2012, Pages 64-69

  Mulcahy, Kylie Patricia ^a   Langdon, Patricia Claire ^a   Mastaglia, Francis ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Deglutition; Deglutition disorders; Incidence; Inflammatory myopathy; Self report

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DERMATOMYOSITIS; DYSPHAGIA; FEMALE; FLUOROSCOPY; FUNCTIONAL ORAL INTAKE SCALE SCORE; HUMAN; INCIDENCE; INCLUSION BODY MYOSITIS; MALE; MD ANDERSON DYSPHAGIA INVENTORY SCORE; MYOSITIS; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF MANAGEMENT OF DYSPHAGIA; SELF REPORT; SELF REPORT OF DYSPHAGIA VIA INTERVIEW; SYDNEY SWALLOW QUESTIONNAIRE SCORE; VIDEOFLUOROSCOPY;

ADULT; AGED; AGED, 80 AND OVER; BARIUM SULFATE; COHORT STUDIES; CONTRAST MEDIA; DEGLUTITION DISORDERS; FEMALE; FLUOROSCOPY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOSITIS; PREVALENCE; SELF REPORT; VIDEO RECORDING;

EID: 84858078979     PISSN: 0179051X     EISSN: 14320460     Source Type: Journal    
DOI: 10.1007/s00455-011-9338-0     Document Type: Article

References (24)

1. Dalakas MC. Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol. 2006;2(8):437-47. (Pubitemid 44137945)
2. Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Basford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc. 2007;82(4):441-7. (Pubitemid 46543468)
3. Mastaglia FL. Inflammatory muscle diseases. Neurol India. 2008;56(3):263-70.
4. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin North Am. 2002;28:723-41. (Pubitemid 36008549)
5. Eckberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia. 2002;17(2):139-46. (Pubitemid 36919842)
6. Cox FM, Verschuuren JJ, Verbist BM, Niks EH, Wintzen AR, Badrising UA. Detecting dysphagia in inclusion body myositis. J Neurol. 2009;256:2009-13.
7. Williams RB, Grehan MJ, Hersch M, Andre J, Cook IJ. Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia. Gut. 2003;42: 471-8. (Pubitemid 36363395)
8. Needham M, James I, Corbett A, Day T, Christiansen F, Phillips B, Mastaglia FL. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry. 2008;79:1056-60.
9. Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol. 2007;6:620-31. (Pubitemid 46921056)
10. Liu LWC, Tarnopolsky M, Armstrong D. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol. 2004;18(6):397-9. (Pubitemid 39076994)
11. Houser SM, Calabrese LH, Strome M. Dysphagia in patients with inclusion body myositis. Laryngoscope. 1998;108(7):1001-5. (Pubitemid 28304914)
12. Nagano H, Yoshifuku K, Kurono Y. Polymyositis with dysphagia treated with endoscopic balloon dilatation. Auris Nasas Larynx. 2009;36:705-8.
13. Parodi A, Caproni M, Marzano AV, De Simone C, La Placa M, Quaglini P, Veller Fornasa C, Zane C, Vaccaro M, Papini M, Fabbri P, Rebora A. Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies. Acta Derm Venereol. 2002;82(1):48-51. (Pubitemid 34450545)
14. Na SJ, Kim SM, Sunwoo IN, Choi YC. Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J Korean Med Sci. 2009;24(4):715-21.
15. Oh TH, Brumfield KA, Hoskin TL, Kasperbauer JL, Basford JR. Dysphagia in inclusion body myositis: clinical features,management and clinical outcomes. Am J PhysMed Rehabil. 2008;87(11):883-9.
16. Badrising UA, Maat-Schiemann ML, Houwelingen JC, van Doorn PA, van Duinen SG, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, Verschuuren JJ, Wintzen AR. Inclusion body myositis: clinical features and clinical course of the disease in 64 patients. J Neurol. 2005;252(12):1448-54. (Pubitemid 41803832)
17. Wallace KL, Middleton S, Cook IJ. Development and validation of a self-report symptom inventory to assess the severity of oralpharyngeal dysphagia. Gastroenterology. 2000;118(4):678-87. (Pubitemid 30171617)
18. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: The M.D. Anderson Dysphagia Inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870-6. (Pubitemid 32619370)
19. Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86(8):1516-29.
20. Logemann J. Role of the modified barium swallow in management of patients with dysphagia. Otolaryngol Head Neck Surg. 1997;116(3):335-8. (Pubitemid 27163688)
21. Nicosia MA, Robbins J. The usefulness of the line spread test as a measure of liquid consistency. Dysphagia. 2007;22(4):306-11. (Pubitemid 47573332)
22. National Institute of Neurological Disorders and Stroke (2010) Inflammatory myopathies fact sheet. http://www.ninds.nih.gov/disorders/ inflammatory-myopathies/detail-inflammatory- myopathies.htm. Accessed 24 July 2010.
23. Green C, Pope C. Gender, psychosocial factors and the use of medical services: a longitudinal analysis. Soc Sci Med. 1999;48(10):1363-72. (Pubitemid 29197338)
24. Wilkins T, Gillies R, Thomas A, Wagner P. The prevalence of dysphagia in primary care patients. J Am Board Fam Med. 2007;20(2):144-55.